Cytomegalovirus pUL97 Kinase Inhibitor
- Name
- Cytomegalovirus pUL97 Kinase Inhibitor
- Accession Number
- DBCAT005655
- Description
Not Available
- Drugs
Drug Drug Description Maribavir A cytomegalovirus (CMV) pUL97 kinase inhibitor used for the treatment of refractory post-transplant CMV infection. - Drugs & Drug Targets
Drug Target Type Maribavir Serine/threonine protein kinase UL97 target Maribavir Cytochrome P450 3A4 enzyme Maribavir Cytochrome P450 1A2 enzyme Maribavir Serum albumin carrier Maribavir Alpha-1-acid glycoprotein 1 carrier Maribavir ATP-binding cassette sub-family G member 2 transporter Maribavir P-glycoprotein 1 transporter